Rosenberg Ellen

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$230,100.00
Insider Sells Quantity
12
Insider Sells Sum
$3.32M

Insider Activity of Rosenberg Ellen

According to the SEC Form 4 filings, Rosenberg Ellen, being in a position of

  1. Chief Legal Officer at Amicus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 95000 shares for $1.31M,
    over all time since 2016-06-02, has bought 30000 shares for $230,100, and sold 285198 shares for $3.32M.

The largest purchase of all time was on 2016-06-02 and amounted to 30000 shares of Amicus Therapeutics, Inc. for $230,100.

The largest sale of all time was on 2020-07-16 and amounted to 60000 shares of Amicus Therapeutics, Inc. for $612,711.

Biography of Rosenberg Ellen

No biography is available at this moment.

2024-02-07SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
29,600
0.0104%
$13.00$384,818-16.35%
2024-02-06SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
400
0.0001%
$13.00$5,200-15.95%
2024-01-02SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
30,000
0.0102%
$14.21$426,219-20.25%
2023-12-27SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
5,000
0.0017%
$14.07$70,327-21.38%
2023-12-26SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
30,000
0.0102%
$14.00$420,084-19.5%
2023-01-24SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
31,839
0.0109%
$13.32$424,006-8.85%
2022-08-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,123
0.0039%
$10.02$111,472+19.86%
2022-06-21SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,122
0.0039%
$10.00$111,272+16.3%
2022-04-07SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,018
0.0038%
$9.06$99,797+22.92%
2020-07-16SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
60,000
0.0154%
$10.21$612,711-8.33%
2020-01-15SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
44,200
0.0171%
$10.35$457,284+35.51%
2020-01-02SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
20,896
0.0081%
$9.56$199,768+44.5%
2016-06-02PurchaseAmicus Therapeutics, Inc.
FOLD
General Counsel & Corp. Secy
30,000
0.0231%
$7.67$230,100-10.12%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.